Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.89
+4.8%
$0.76
$0.63
$2.57
$41.41M0.81152,160 shs72,608 shs
PAVmed Inc. stock logo
PAVM
PAVmed
$5.21
+5.9%
$5.21
$3.85
$28.44
$39.34M0.5447,309 shs31,437 shs
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
$2.04
+2.0%
$2.59
$1.23
$15.50
$10.36MN/A56,175 shs24,386 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.69
+0.2%
$7.09
$4.50
$42.75
$40.20M1.4888,621 shs45,532 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%-5.53%+30.77%-14.14%-65.16%
PAVmed Inc. stock logo
PAVM
PAVmed
0.00%-5.02%-0.61%-20.00%-66.19%
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
0.00%-4.76%+14.94%+22.70%+199,999,900.00%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%+1.52%-24.15%-70.47%-88.76%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.89
+4.8%
$0.76
$0.63
$2.57
$41.41M0.81152,160 shs72,608 shs
PAVmed Inc. stock logo
PAVM
PAVmed
$5.21
+5.9%
$5.21
$3.85
$28.44
$39.34M0.5447,309 shs31,437 shs
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
$2.04
+2.0%
$2.59
$1.23
$15.50
$10.36MN/A56,175 shs24,386 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.69
+0.2%
$7.09
$4.50
$42.75
$40.20M1.4888,621 shs45,532 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%-5.53%+30.77%-14.14%-65.16%
PAVmed Inc. stock logo
PAVM
PAVmed
0.00%-5.02%-0.61%-20.00%-66.19%
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
0.00%-4.76%+14.94%+22.70%+199,999,900.00%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%+1.52%-24.15%-70.47%-88.76%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50405.16% Upside
PAVmed Inc. stock logo
PAVM
PAVmed
2.00
Hold$56.00974.86% Upside
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
4.00
Strong BuyN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
2.50
Moderate Buy$51.00987.42% Upside

Current Analyst Ratings Breakdown

Latest RGNT, SNWV, NSPR, and PAVM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeHold (C)Hold (C-)
8/14/2026
PAVmed Inc. stock logo
PAVM
PAVmed
DowngradeSell (D)Sell (E+)
8/11/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
UpgradeHold (C-)Hold (C)
7/17/2026
PAVmed Inc. stock logo
PAVM
PAVmed
Reiterated RatingSell (D)
6/24/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Reiterated RatingHold (C-)
6/8/2026
PAVmed Inc. stock logo
PAVM
PAVmed
Lower Price TargetBuy$65.00 ➝ $56.00
(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.84M3.82N/AN/A$1.83 per share0.49
PAVmed Inc. stock logo
PAVM
PAVmed
$70K595.43N/AN/A($2.42) per share-2.15
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/AN/AN/AN/A$0.92 per shareN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$44.05M0.92$1.71 per share2.75$0.19 per share24.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.64N/AN/AN/A-413.96%-69.42%-57.68%N/A
PAVmed Inc. stock logo
PAVM
PAVmed
$400K-$16.05N/AN/AN/A-10,794.64%-126.43%-25.49%11/12/2026 (Estimated)
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
-$13.65MN/AN/AN/AN/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$11.81M$0.2419.54N/AN/A32.38%1,728.10%39.04%11/6/2026 (Estimated)

Latest RGNT, SNWV, NSPR, and PAVM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.03-$0.08-$0.05-$0.08$11.50 million$9.74 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
N/AN/AN/AN/AN/A
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
PAVmed Inc. stock logo
PAVM
PAVmed
0.98
1.19
1.19
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/A
2.65
2.65
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
4.87
1.28
0.89

Institutional Ownership

CompanyInstitutional Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
PAVmed Inc. stock logo
PAVM
PAVmed
19.93%
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%

Insider Ownership

CompanyInsider Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
24.98%
PAVmed Inc. stock logo
PAVM
PAVmed
13.40%
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5046.49 million18.33 millionOptionable
PAVmed Inc. stock logo
PAVM
PAVmed
908.00 million6.93 millionNo Data
Regentis Biomaterials Ltd. stock logo
RGNT
Regentis Biomaterials
N/A5.18 millionN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.60 million7.36 millionN/A

Recent News About These Companies

Sanuwave Health Q2 Earnings Call Highlights
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Health Updates Second Quarter 2026 Guidance

New MarketBeat Followers Over Time

Media Sentiment Over Time

InspireMD stock logo

InspireMD NYSE:NSPR

$0.89 +0.04 (+4.80%)
As of 04:00 PM Eastern

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

PAVmed stock logo

PAVmed NASDAQ:PAVM

$5.21 +0.29 (+5.89%)
As of 04:00 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Regentis Biomaterials stock logo

Regentis Biomaterials NYSEAMERICAN:RGNT

$2.04 +0.04 (+2.00%)
As of 04:10 PM Eastern

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$4.69 +0.01 (+0.21%)
As of 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.